Eton Pharmaceuticals, Inc. reported its third quarter financial results for the period ending September 30, 2025, on November 6, 2025, including metrics like Adjusted EBITDA to evaluate performance. This filing is significant for investors as it provides insights into the company's operating performance and financial condition.